August 31, 2016 12:24 AM ET

Pharmaceuticals

Company Overview of RespireRx Pharmaceuticals Inc.

Executive Profile

James S. J. Manuso Ph.D., MBA

Vice Chairman, Chief Executive Officer and President, RespireRx Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 6 different industries.

See Board Relationships
67$1,932,767
As of Fiscal Year 2015

Background

Dr. James S. J. Manuso, also known as Jim, PhD, MBA has been Vice Chairman, Chief Executive Officer and President at Cortex Pharmaceuticals, Inc. since August 18, 2015. Dr. Manuso serves as Chief Business Officer of Symbiontics, Inc. and ZyStor Therapeutics, Inc. Dr. Manuso served as Chairman and Chief Executive Officer of Astex Pharmaceuticals, Inc. from January 1, 2004 to October 2013. He served as the President of Astex Pharmaceuticals, Inc. from January 1, 2004 to ...

Corporate Headquarters

126 Valley Road
Glen Rock, New Jersey 07452

United States

Phone: 201-444-4947
Fax: --

Board Members Memberships

Director
Director
2001-Present
Director
2015-Present
Vice Chairman, Chief Executive Officer and President

Education

MBA
Columbia Business School
BA
New York University
PhD
Graduate Faculty of The New School University

Other Affiliations

Annual Compensation

Salary$146,060
Total Annual Compensation$146,060

Stocks Options

Restricted Stock Awards$1,786,707
Exercisable Options$42,540,650
Total Number of Options$85,081,300

Total Compensation

Total Annual Cash Compensation$146,060
Total Short Term Compensation$146,060
Other Long Term Compensation$1,786,707
Total Calculated Compensation$1,932,767
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.9M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
$5.2M
Elliot Goldstein M.D.Chief Executive Officer, President and Director
ProMIS Neurosciences Inc.
$156.0K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact RespireRx Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.